Antibiotic-Associated Diarrhea Beyond C. Difficile: A Scoping Review.
Vijairam Selvaraj1, Mohd Amer Alsamman2
1Department of Medicine The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Antibiotic-associated diarrhea (AAD) stems from gut microbiota disruption. This review clarifies the roles of *Clostridioides difficile* and other microbes in AAD pathogenesis.
Area of Science:
- Gastroenterology
- Microbiology
- Pharmacology
Background:
- Antibiotic use frequently leads to diarrheal illness.
- Antibiotic-associated diarrhea (AAD) pathogenesis involves gut microbiota alteration, pathogen overgrowth, and drug toxicity.
- Less than 33% of AAD cases are linked to *Clostridioides difficile* (CDI), indicating other causes remain poorly understood.
Purpose of the Study:
- To systematically review existing data on AAD.
- To elucidate the pathogenic mechanisms of both CDI and non-CDI AAD.
- To provide a comprehensive understanding of AAD etiology.
Main Methods:
- Systematic review of current literature on AAD.
- Analysis of data on microbial alterations and opportunistic pathogen proliferation.
- Inclusion of figures detailing pathogenic mechanisms.
Main Results:
- Established pathogenesis of *Clostridioides difficile* infection (CDI).
- Identified unclear roles and mechanisms for other putative microbial causes of AAD, including *Clostridium perfringens*, *Staphylococcus aureus*, *Klebsiella oxytoca*, and *Candida species*.
- Highlighted significant gaps in diagnosing and treating non-CDI AAD.
Conclusions:
- AAD is a complex condition with multiple potential microbial triggers beyond *C. difficile*.
- Further research is needed to clarify the pathogenesis of non-CDI AAD.
- Improved diagnostic and therapeutic strategies are required for the majority of AAD cases.
More Related Videos
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
